Oyama, Japan

Masahiro Iwamoto

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2011-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Iwamoto. Retrieved from https://idiyas.com/inventor/masahiro-iwamoto-mm41698r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masahiro Iwamoto: Innovator in Therapeutic Agents

Introduction

Masahiro Iwamoto is a notable inventor based in Oyama, Japan. He has made significant contributions to the field of medicine, particularly in developing therapeutic agents for chronic arthritides diseases in children. With a total of 2 patents to his name, Iwamoto's work is paving the way for advancements in pediatric healthcare.

Latest Patents

Iwamoto's latest patents focus on a therapeutic agent for chronic arthritides diseases related to childhood. This innovative agent comprises an interleukin-6 (IL-6) antagonist as an active ingredient. His work addresses critical conditions such as Still's disease, providing new hope for affected children.

Career Highlights

Iwamoto is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company. His role at Chugai has allowed him to engage in groundbreaking research and development, contributing to the advancement of medical treatments.

Collaborations

Throughout his career, Iwamoto has collaborated with esteemed colleagues, including Seiji Minota and Kazuyuki Yoshizaki. These partnerships have fostered a collaborative environment that enhances innovation and research in therapeutic solutions.

Conclusion

Masahiro Iwamoto's contributions to the field of medicine, particularly in developing therapeutic agents for childhood diseases, highlight his dedication to improving pediatric healthcare. His innovative work continues to inspire advancements in the medical community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…